Progress on miRNAs in Esophageal Squamous Cell Carcinoma

ZHANG Cong; DAI Tianyang

doi:10.3971/j.issn.1000-8578.2015.02.023

Cancer Research on Prevention and Treatment > 2015 > 42(02): 204-208. > DOI: 10.3971/j.issn.1000-8578.2015.02.023

ZHANG Cong, DAI Tianyang. Progress on miRNAs in Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 204-208. DOI: 10.3971/j.issn.1000-8578.2015.02.023

Citation:

ZHANG Cong, DAI Tianyang. Progress on miRNAs in Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 204-208. DOI: 10.3971/j.issn.1000-8578.2015.02.023

Citation:

ZHANG Cong, DAI Tianyang. Progress on miRNAs in Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 204-208. DOI: 10.3971/j.issn.1000-8578.2015.02.023

PDF (1531 KB)

Progress on miRNAs in Esophageal Squamous Cell Carcinoma

ZHANG Cong¹,
DAI Tianyang^2, ,

1. Affiliated Hospital of Luzhou Medical College, Luzhou 646000, China; 2. Department of Cardiothoracic Surgery, Affiliated Hospital of Luzhou Medical College, Luzhou 646000,China

More Information

Received Date: July 24, 2014
Revised Date: September 23, 2014

Graphical Abstract

Abstract

Abstract

Esophageal squamous cell carcinoma(ESCC) is the major subtype of esophageal cancer(EC) in China. Although the molecular genetics of ESCC have been widely studied, the molecular mechanism of ESCC carcinogenesis has not been completely understood. microRNAs(miRNAs) are a class of small, endogenous, and non-protein-coding RNAs. They have a role in biological and pathological process, including cell differentiation, apoptosis, proliferation and metabolism. miRNAs have a potential role in ESCC pathogenesis through oncogenes or tumor suppressor genes. Recent years, some studies show that a substantial number of miRNAs are differentially expressed in esophageal cancer tissues. A better knowledge of the roles of miRNAs and their target genes in ESCC development may provide new avenues for the early detection, diagnosis, therapy, and prognosis of ESCC.
- miRNAs,
- Esophageal squamous cell carcinoma (ESCC),
- Target genes

FullText(HTML)

References (35)

References

[1]	Garzon R, Calin GA, Croce CM. microRNAs in cancer[J]. Annu Rev Med, 2009, 60: 167-79.
[2]	Zhang C, Wang C, Chen X, et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma[J]. Clin Chem, 2010, 56(12): 1871-9.
[3]	Chen X, Hu H, Guan X, et al. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma[J]. Int J Cancer, 20 12, 130(7): 1607-13.
[4]	Guo Y, Chen Z, Zhang L, et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma[J]. Cancer Res, 2008, 68(1): 26-33.
[5]	Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes[J]. Biochem Soc Trans, 2009, 37(Pt 4): 91 8-25.
[6]	Chen ZL, Zhao XH, Wang JW, et al. microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin[J]. J Biol Chem, 2011, 286(12): 10 725-34.
[7]	Tian Y, Luo A, Cai Y, et al. microRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines[J]. J Biol Chem, 2010, 285(11): 7986-94.
[8]	Zhang T, Wang Q, Zhao D, et al. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma[J]. Clin Sci (Lond), 2011, 121(10): 437-47.
[9]	Hong L, Han Y, Zhang H, e t al . The prognos t i c and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma[J]. Ann Surg, 2010, 251(6): 1056-63.
[10]	He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network[J]. Nature, 2007, 447(7148): 1130-4.
[11]	Matsushima K, Isomoto H, Yamaguchi N, et al. miRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells[J]. J Transl Med, 2011, 9: 30.
[12]	Lee KH, Goan YG, Hsiao M, et al. microRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2( LATS2) and stimulates proliferation in human esophageal cancer[J]. Exp Cell Res, 2009, 315(15): 2529-38.
[13]	Kurashige J, Watanabe M, Iwatsuki M, et al. Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma[J]. Br J Cancer, 2012, 10 6(1): 182-8.
[14]	Zhang T, Zhao D, Wang Q, et al. microRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma[J]. Mol Carcinog, 2012, 52(8): 581-90.
[15]	Zhang HF, Zhang K, Liao LD, et al. miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2[J]. Carcinogenesis, 2014, 35(2): 292-301.
[16]	Liu Q, Lv GD, Qin X, et al. Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma[J]. Mol Biol Rep, 2012, 39(2):1239-46.
[17]	Kong KL, Kwong DL, Chan TH, et al. microRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor[J]. Gut, 2012, 61(1): 33-42.
[18]	Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update[J]. Nat Rev Cancer, 2012, 12(3): 15 9-69.
[19]	Ding DP, Chen ZL, Zhao XH, et al. miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression[J]. Carcinogenesis, 2011, 32(7): 1025-32.
[20]	Yuan Y, Zeng ZY, Liu XH, et al. microRNA-203 inhibits cell proliferation by repressing DeltaNp63 expression in human esophageal squamous cell carcinoma[J]. BMC Cancer, 2011, 11: 57.
[21]	Kano M, Seki N, Kikkawa N, et al. miR-145, miR-133a and miR- 13 3b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma[J]. Int J Cancer, 2010, 127(12): 2804-14.
[22]	Tsuchiya S, Fujiwara T, Sato F, et al. microRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1(FGFRL1)[J]. J Biol Chem, 2011, 286(1): 420-8.
[23]	Kurashige J, Kamohara H, Watanabe M, et al. Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma[J]. J Surg Oncol, 2012, 106(2): 188-92.
[24]	Komatsu S, Ichikawa D, Takeshita H, et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma[J]. Br J Cancer, 2011, 105 (1): 104-11.
[25]	Ogawa R, Ishiguro H, Kuwabara Y, et al. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR[J]. Med Mol Morphol, 2009, 42(2): 102-9.
[26]	Zhu L, Yan W, Rodriguez-Canales J, et al. microRNA analysis of microdissected normal squamous esophageal epithelium and tumor cells[J]. Am J Cancer Res, 2011, 1(5): 574-84.
[27]	Feber A, Xi L, Luketich JD, et al. MicroRNA expression profiles of esophageal cancer[J]. J Thorac Cardiovasc Surg, 2008, 135 (2): 25 5-60.
[28]	Ma WJ, Lv GD, Tuersun A, et al. Role of microRNA-21 and effect on PTEN in Kazakh’s esophageal squamous cell carcinoma[J]. Mol Biol Rep, 2011, 38(5): 3253-60.
[29]	Akagi I, Miyashita M, Ishibashi O, et al. Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma[J]. Dis Esophagus, 2011, 24(7): 523-30.
[30]	Xu X, Chen Z, Zhao X, et al. microRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma[J]. Biochem Biophys Res Commun, 2012, 421(4): 640-5.
[31]	Zhang H, Li M, Han Y, et al. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma[J]. Dig Dis Sci, 2010, 55(9): 2545-51.
[32]	Feng DD, Zhang H, Zhang P, et al. Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia[J]. J Cell Mol Med, 2011, 15(10): 2164-75.
[33]	Sugimura K, Miyata H, Tanaka K, et al. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma[J]. Clin Cancer Res, 2012, 18(18): 5144-53.
[34]	Li S, Li Z, Guo F, et al. miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma[J]. J Biomed Sci, 2011, 18: 24.
[35]	Li J, Li X, Li Y, et al. Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization[J]. PLoS One, 2013, 8(1): e53582.

[2]	Luo Zhaoqin, Zhao Bingbing, Zhang Wei, Wang Qi, Pan Zhongmian, Yang Zhijun, Li Li. Diagnostic Value of Serum HE4 in Ovarian Tumor[J]. Cancer Research on Prevention and Treatment, 2012, 39(03): 312-317. DOI: 10.3971/j.issn.1000-8578.2012.03.017
[3]	WU Jun, YANG Tai-cheng, LAI Huang-wen, et al, . Induction of CEA-Specific cytotoxic T lymphocytes by dendritic cells transfected with CEA-recombinant vaccinia virus[J]. Cancer Research on Prevention and Treatment, 2002, 29(05): 353-355. DOI: 10.3971/j.issn.1000-8578.795
[4]	XIONG Qin'e, WU Guo-jun, ZHU Guo-xin, et al, . The Clinical Signification of CEA Value of Cholecytic Bile for Diagnosis of Colonic Cancer Metastased to liver[J]. Cancer Research on Prevention and Treatment, 2000, 27(06): 466-467. DOI: 10.3971/j.issn.1000-8578.1220
[5]	Shen Jingbo, . The Immunohis tochemical Study of Carcinoembryonic Antigen in Uterous Endometrium Hyperplasia[J]. Cancer Research on Prevention and Treatment, 1998, 25(2): 83-85.
[6]	Gao JianFei, . Comparative observation of Blood ANP、Gastrin、CEA in Patients with lung Cancer[J]. Cancer Research on Prevention and Treatment, 1997, 24(6): 349-351.
[7]	Bi Huimin, . Selective Expression of CEA, K147+HK₂, K27 and Vimentin in Fine needle Aspirates of Lymph Node Tumors[J]. Cancer Research on Prevention and Treatment, 1995, 22(6): 350-352.
[8]	Wang Hongwu, . Measurement of LSA, HcG, β₂-MG, CEA on Lung Neoplasma[J]. Cancer Research on Prevention and Treatment, 1995, 22(6): 329-332.
[9]	Du Weidong, . Immunohistochemical locali}ations of the carcinoembrynic antigen，epithelial membrane antigen and IV type collagen of stomach carcinoma in relation to differentiation invasion and metastasis[J]. Cancer Research on Prevention and Treatment, 1994, 21(4): 202-204.
[10]	Zhou BenCheng, . THE IMMUNOHISTOCHEMICAL STUDY OF CARCINOEMHRYONIC ANTIGEN IN DYSPLASIA AND CARCINDMA IN SITU OF THE CERVIX[J]. Cancer Research on Prevention and Treatment, 1991, 18(1): 26-28.

Cited By

Get Citation

PDF

XML

Article views (1766) PDF downloads (563)

Turn off MathJax

Article Contents

Abstract

References

Progress on miRNAs in Esophageal Squamous Cell Carcinoma

Abstract

References

Related Articles

Catalog

Contact Us

Progress on miRNAs in Esophageal Squamous Cell Carcinoma

Abstract

References

Related Articles

Catalog

Contact Us

Export File

Citation

Format

Content